Ambri gets new business software
Wednesday, 01 May, 2002
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.
Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.
"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
